Natural Alternatives to Vioxx, Celebrex & Other Anti-Inflammatory Prescription Drugs, Second Edition (The Square One Health Guides)
Description:
Written by health professionals who are well recognized in their respective fields, these concise, easy-to-read books focus on a wide range of important health concerns. From migraine headaches to high cholesterol, each title looks at a specific problem; each provides a clear explanation of the disorder, its causes, and its symptoms; and each offers natural solutions that can either greatly reduce or completely eliminate the problem. Some titles also focus on natural alternatives to drugs with serious side effects―alternatives that in many cases can be used in conjunction with prescription medications. This growing series of titles can be counted on to provide safe and sensible solutions to all-too-common health problems.
Best prices to buy, sell, or rent ISBN 9780757002786
Frequently Asked Questions about Natural Alternatives to Vioxx, Celebrex & Other Anti-Inflammatory Prescription Drugs, Second Edition (The Square One Health Guides)
The price for the book starts from $10.85 on Amazon and is available from 16 sellers at the moment.
If you’re interested in selling back the Natural Alternatives to Vioxx, Celebrex & Other Anti-Inflammatory Prescription Drugs, Second Edition (The Square One Health Guides) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Natural Alternatives to Vioxx, Celebrex & Other Anti-Inflammatory Prescription Drugs, Second Edition (The Square One Health Guides) book, the best buyback offer comes from and is $ for the book in good condition.
The Natural Alternatives to Vioxx, Celebrex & Other Anti-Inflammatory Prescription Drugs, Second Edition (The Square One Health Guides) book is in very low demand now as the rank for the book is 4,441,053 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.